Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. - Wikidata - wikimedia - TriplyDB

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

http://www.wikidata.org/entity/Q36821101

about

Modulation of Immune Responses by Exosomes Derived from Antigen-Presenting Cells Extracellular Vesicles in Chronic Obstructive Pulmonary Disease Exosomes in tumor microenvironment: novel transporters and biomarkers Extracellular Vesicles in Angiogenesis.Extracellular vesicles: masters of intercellular communication and potential clinical interventions.CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond.The multifaceted role of extracellular vesicles in metastasis: Priming the soil for seeding.Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.Dendritic cell-derived exosomes for cancer therapy.Donor-derived exosomes: the trick behind the semidirect pathway of allorecognition.Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells.Exosomes in cancer theranostic: Diamonds in the rough.The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.The Unique Molecular and Cellular Microenvironment of Ovarian Cancer RIG-I activation induces the release of extracellular vesicles with antitumor activity.Harnessing the immune response to target tumors.Extracellular Vesicle Biology in the Pathogenesis of Lung Disease.Extracellular vesicles of ETV2 transfected fibroblasts stimulate endothelial cells and improve neovascularization in a murine model of hindlimb ischemia.Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges.The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency.Stem-cell extracellular vesicles and lung repair.Biological roles and potential applications of immune cell-derived extracellular vesicles.Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.In vitro toxicology studies of extracellular vesicles.Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo.Extracellular Vesicle MicroRNA Transfer in Lung Diseases.Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.Qualitative differences in T-cell activation by dendritic cell-derived extracellular vesicle subtypes.Multiplexed Profiling of Single Extracellular Vesicles.Shedding light on the cell biology of extracellular vesicles.The Secret Life of Exosomes: What Bees Can Teach Us About Next-Generation Therapeutics.Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes.Exosome-Based Cell-Cell Communication in the Tumor Microenvironment.Exosomes and Immune Response in Cancer: Friends or Foes?Tumor exosomes: a double-edged sword in cancer therapy.Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery.

P2860

Q28066545-FA8BF280-4D9C-4B62-B1B6-F06A693BA6DE Q28078352-A1ECBD36-8A5C-4964-B519-EA9E8D2C3AAF Q28079003-19BE4018-6DA4-4269-B451-1F35EE05F064 Q33663907-EB5C2AD4-C1C7-41D4-8184-16DFEB48363A Q36737922-4F207EC8-5FE2-4AFF-9A1E-D0864121D674 Q37654516-87EB9417-01A6-43BD-B6D3-E308388470C1 Q37699374-A9C08399-FB7F-4ACB-8039-9644F30AFE1A Q38636468-A7F10F7B-7B9C-4A41-8C57-FC906217FAF2 Q38770064-21F3F424-C553-4E2F-9F29-CE7EB7B6A585 Q38783439-E677EB1F-5643-442F-836A-68801AC01870 Q38795623-EA84D086-FDF4-43DC-889C-FF6A1984DD96 Q39023591-1A448313-295B-4F39-B0E6-390D67D1BB3E Q39105855-D393F07F-D542-473B-A83F-FC8DC65A4032 Q39122582-1F44884B-F29D-4BFE-94DD-E57D8882B1E0 Q39123707-747EC1DA-3484-4AA2-BF17-8854E259E31D Q39169603-85311DBE-C1F0-419B-BCD3-1EAD067BE2A7 Q39181844-F85409E7-AD46-4180-AB43-3D4D68A39C7B Q39377265-EE791FF8-B3EB-4A10-B77A-7877A8F5AB16 Q40134679-AC46A49E-5E82-4BD4-9D2C-A4059A40F025 Q40217744-485BF200-2E04-4D74-AE89-0A0CE5137ED7 Q41034165-505A91D7-65A0-4E9A-A8EC-8B75006B7700 Q42344436-38320C26-F9BE-4AC5-9DB7-C6F9217DA972 Q42654753-7E9D977C-BA8F-4155-A15E-4BEB864D23E1 Q44794582-059674B7-D70D-44AC-856E-0EEC7C5F8521 Q45542402-3E3DA21F-C94A-4FFD-A94A-372BD5547881 Q46193686-03841B86-B512-4704-9F0B-C3637F4A3F9C Q46268171-00979CDA-3CA9-499F-BEF5-21BA421DE5C7 Q46514158-D5CCEB67-C22D-4646-97D1-B1299440F748 Q47134693-E9FD17AE-A626-47CE-9493-694F8187CB73 Q47219580-83177F80-CEE4-4CAC-92E0-63D0A58B1D6B Q47622685-9E99593D-A624-4A5E-931C-2CB8B2CD834F Q47782537-0AFB6666-7426-4CD3-A847-33E228AD5A08 Q48331642-EABB347B-CB04-43F3-9A49-3932AEE0CE61 Q50018560-E30EBACD-80A2-4E4F-AD05-40FDF6B5AD95 Q50081195-23442026-E817-473E-9E8E-3A9E532CC983 Q51734143-78517711-F061-4841-B12D-54CB3B8C2E19 Q52363481-1520E518-1DC0-45DC-A2C8-5E0B06A8EC8E Q52562641-F70FDC3A-35FF-4378-9580-BB4A389044F5 Q52654592-B9B7DFDA-215B-498A-8E14-5023782AF214 Q52726716-6987C52B-89BA-4365-89F0-AC3A8A2313BA

P2860

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

http://www.wikidata.org/entity/Q36821101

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dendritic cell-derived exosome ...... st line chemotherapy in NSCLC.

@en

type

label

Dendritic cell-derived exosome ...... st line chemotherapy in NSCLC.

@en

prefLabel

Dendritic cell-derived exosome ...... st line chemotherapy in NSCLC.

@en

P1433

Q36821101-1E4567B7-2A8C-441D-9882-C6F1B9A67CB6

P1476

Q36821101-993183E7-5DDD-41B5-AA8F-36C0F2D3810D

P2093

Q36821101-10C8BAF1-EACA-44D5-8B40-100E3A8F41FE

Q36821101-13C4FD6F-8ED7-4AA9-8E0F-75420A321497

Q36821101-31A361F7-3A61-4DF6-BCE5-D21B6CB282F7

Q36821101-45C618C4-822D-461C-893F-CB4CDD566B27

Q36821101-4FF815D9-164C-425B-B974-CF9AA00B9D71

Q36821101-5655689B-0F6B-4676-9C24-6D022110D087

Q36821101-67568D00-A4C0-426C-A2AF-FE326A33FD92

Q36821101-79E2EEC0-9864-4DD3-8573-B86E6B83B133

Q36821101-7AE2F665-CA5E-42D3-A06A-31B64DE8B684

Q36821101-7EBB176F-DF5B-4CC0-AF1A-7274BBB56E63

P2860

Q36821101-073E7996-F025-4EED-AB3E-E67459FC89A6

Q36821101-119F6067-DD24-4EA2-9601-9307352D9B2E

Q36821101-15E29BCE-51B6-4A81-91A8-CC1DC1F67076

Q36821101-1921AF54-13CD-4738-BB04-5C26B5FEE0AC

Q36821101-1A543133-2D68-4D99-B12F-239ACD6B2449

Q36821101-1E48FE59-CE47-4FEF-82C7-AAF9A4DF0B78

Q36821101-282507C3-9F0B-4F2D-A73D-0793EF7047D4

Q36821101-283E9E34-3460-4F74-A215-FC1F94C49EA4

Q36821101-2DEE6DC1-2DF4-47D4-961F-960CF3EFBF95

Q36821101-30392516-EBDC-4F3B-94CD-49CAD31B3C19

P304

Q36821101-C5082ABD-CA2B-4809-97FE-078ECFCD5EEE

P31

Q36821101-4C00C86D-9403-42E0-A7E3-E32EF47AFE91

P356

Q36821101-FCDF6670-E6DD-4B4D-B502-6B99E7F8D412

P433

Q36821101-687FB50C-301D-4EF6-AE37-9457DEDFC675

P478

Q36821101-D2869120-D4AB-4CBA-8C2E-8F3F8A9F0273

P50

Q36821101-3413D524-6CF0-41AB-A0D5-2A268CF54FEA

Q36821101-4DD95359-0DD4-4477-9211-1336B2728C1F

Q36821101-62237A42-7AA8-4262-9452-F18034DDDE2B

Q36821101-7F5D3CF0-2871-433C-8BF5-C7AFF0105E78

Q36821101-8C4CFA75-54EE-4F9A-94FC-D340B7AF6FB7

Q36821101-8E607418-960A-487B-87AF-E51DBD5443F8

Q36821101-8F894931-246E-4D32-9404-43217A73A2D0

Q36821101-CDFFBAF5-834E-4B08-B5F0-47EDA64A6A94

Q36821101-D6B52E2C-AFFA-4E5D-85EE-9E37E03036B5

Q36821101-D7E314A9-367A-467D-8B72-94AFC5FC8D2F

P577

Q36821101-55708D69-1755-4983-9877-BED703D9B077

P698

Q36821101-B915296B-464D-49A1-BC4A-CA0E070920EF

P921

Q36821101-12365853-3522-4A8C-BB47-E97A934D3972

Q36821101-2F9236A4-1765-4216-B7C3-03F3F2E4F112

P932

Q36821101-A1DB268F-C3D0-4F0B-9CD6-F4417354785C

P356

2162402X.2015.1071008

P1433

P1476

Dendritic cell-derived exosome ...... st line chemotherapy in NSCLC.

@en

P2093

Agnès Laplanche

http://www.w3.org/2001/XMLSchema#string

Alain Livartoski

http://www.w3.org/2001/XMLSchema#string

Benjamin Besse

http://www.w3.org/2001/XMLSchema#string

David Planchard

http://www.w3.org/2001/XMLSchema#string

Eric Dansin

http://www.w3.org/2001/XMLSchema#string

Fabrice Barlesi

http://www.w3.org/2001/XMLSchema#string

Inka Zoernig

http://www.w3.org/2001/XMLSchema#string

Isabelle Peguillet

http://www.w3.org/2001/XMLSchema#string

Jonathan M Pitt

http://www.w3.org/2001/XMLSchema#string

Katrin S Reiners

http://www.w3.org/2001/XMLSchema#string

P2860

Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

Regulation of immune responses by extracellular vesicles

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.

Oncology meets immunology: the cancer-immunity cycle.

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

P304

e1071008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1071008

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Alexander Eggermont

Jean-Charles Soria

Thierry Le Chevalier

Nathalie Chaput

Sylvie Rusakiewicz

Frédéric Vély

Clotilde Théry

P577

2015-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27141373

http://www.w3.org/2001/XMLSchema#string

P921

P932

4839329

http://www.w3.org/2001/XMLSchema#string